Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Acutus Medical ( (AFIB) ) is now available.
Acutus Medical has announced a significant downsizing, reducing its workforce by 70% to focus solely on fulfilling obligations to Medtronic for left-heart access products. This strategic move aims to cut costs while leveraging potential earnout payments from Medtronic until 2027. The transition will include operational changes and a shift in CEO and CFO roles, with the company continuing to support Medtronic through contract manufacturing. The downsizing is expected to be largely complete by Q1 2025.
For a thorough assessment of AFIB stock, go to TipRanks’ Stock Analysis page.